dc.contributorGordillo-Bastidas, D., Institute of Molecular Biology in Medicine and Gene Therapy/CUCS, University of Guadalajara, Guadala jara, Jalisco 44100, Mexico; Oceguera-Contreras, E., Institute of Molecular Biology in Medicine and Gene Therapy/CUCS, University of Guadalajara, Guadala jara, Jalisco 44100, Mexico; Salazar-Montes, A., Institute of Molecular Biology in Medicine and Gene Therapy/CUCS, University of Guadalajara, Guadala jara, Jalisco 44100, Mexico; González-Cuevas, J., Institute of Molecular Biology in Medicine and Gene Therapy/CUCS, University of Guadalajara, Guadala jara, Jalisco 44100, Mexico; Hernández-Ortega, L.D., Institute of Molecular Biology in Medicine and Gene Therapy/CUCS, University of Guadalajara, Guadala jara, Jalisco 44100, Mexico; Armendáriz-Borunda, J., Institute of Molecular Biology in Medicine and Gene Therapy/CUCS, University of Guadalajara, Guadala jara, Jalisco 44100, Mexico
dc.creatorGordillo-Bastidas, D.
dc.creatorOceguera-Contreras, E.
dc.creatorSalazar-Montes, A.
dc.creatorGonzalez-Cuevas, J.
dc.creatorHernandez-Ortega, L.D.
dc.creatorArmendariz-Borunda, J.
dc.date.accessioned2015-11-19T18:51:27Z
dc.date.accessioned2023-07-03T23:13:42Z
dc.date.available2015-11-19T18:51:27Z
dc.date.available2023-07-03T23:13:42Z
dc.date.created2015-11-19T18:51:27Z
dc.date.issued2013
dc.identifierhttp://hdl.handle.net/20.500.12104/66614
dc.identifier10.3748/wjg.v19.i47.9020
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-84890952351&partnerID=40&md5=10b61d741cedbcf00f86f3c1786d0128
dc.identifierhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=medl&AN=24379627
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/7248694
dc.description.abstractAIM: To determine the molecular mechanisms involved in experimental hepatic fibrosis prevention by caffeine (CFA). METHODS: Liver fibrosis was induced in Wistar rats by intraperitoneal thioacetamide or bile duct ligation and they were concomitantly treated with CFA (15 mg/kg per day). Fibrosis and inflammatory cell infiltrate were evaluated and classified by Knodell index. Inflammatory infiltrate was quantified by immunohistochemistry (anti-CD11b). Gene expression was analyzed by quantitative reverse transcription-polymerase chain reaction for collagen I (Col-1), connective tissue growth factor (CTGF), transforming growth factor β1 (TGF-β1), tumor necrosis factor alpha (TNF-α), interleukin-1 (IL-1), IL-6, superoxide dismutase (SOD) and catalase (CAT). Activation of Nrf2 and Snail-1 was analyzed by Western-blot. TNF-α expression was proved by enzyme-linked immunosorbant assay, CAT activity was performed by zymography. RESULTS: CFA treatment diminished fibrosis index in treated animals. The Knodell index showed both lower fibrosis and necroinflammation. Expression of profibro-genic genes CTGF, Col-1 and TGF-β1 and proinflam-matory genes TNF-α, I L- 6 and IL- 1 was substantially diminished with CFA treatment with less CD11b positive areas. Significantly lower values of transcriptional factor Snail-1 were detected in CFA treated rats compared with cirrhotic rats without treatment; in contrast Nrf2 was increased in the presence of CFA. Expression of SOD and CAT was greater in animals treated with CFA showing a strong correlation between mRNA expression and enzyme activity. CONCLUSION: Our results suggest that CFA inhibits the transcriptional factor Snail-1, down-regulating profi-brogenic genes, and activates Nrf2 inducing antioxidant enzymes system, preventing inflammation and fibrosis. © 2013 Baishideng Publishing Group Co., Limited. All rights reserved.
dc.relationWorld Journal of Gastroenterology
dc.relation19
dc.relation47
dc.relation9020
dc.relation9033
dc.relationScopus
dc.relationWOS
dc.relationMEDLINE
dc.titleNrf2 and Snail-1 in the prevention of experimental liver fibrosis by caffeine
dc.typeArticle


Este ítem pertenece a la siguiente institución